Rlavie Successfully Concludes CPHI Shanghai 2026
Rlavie successfully participated in CPHI Shanghai 2026, showcasing custom synthesis, heterocyclic chemistry, and reliable pharmaceutical chemical supply solutions worldwide.
Rlavie is proud to have successfully concluded our participation in CPHI Shanghai 2026, held from June 16–18.
Throughout the three-day exhibition, our team had the pleasure of meeting customers, partners, and industry professionals from around the world. At our booth, we engaged in productive discussions on heterocyclic chemistry, custom synthesis, building blocks, and reliable supply solutions for pharmaceutical research and development.
The exhibition provided an excellent opportunity to strengthen existing partnerships, establish new connections, and exchange insights on the latest developments in the pharmaceutical industry.
We sincerely appreciate everyone who visited our booth and shared valuable conversations with us. Your trust and interest continue to inspire our commitment to delivering high-quality chemical products, responsive technical support, and dependable service.
As we move forward, Rlavie remains dedicated to supporting pharmaceutical companies, CROs, and research institutions worldwide through innovation, quality, and long-term collaboration.
Thank you for being part of our CPHI Shanghai 2026 journey. We look forward to seeing you again at future industry events.